PlainPharmaWatch

CMS Open Payments · Program Year 2024

Boehringer Ingelheim Espana S.A.

Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals across 32 transactions.

$382.8K
Total payments
32
Transactions
2
Recipients
#837
of 1,925 companies

Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #837 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $191.4K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

Boehringer Ingelheim Espana S.A. pairs above-median payment volume with a concentrated payment pattern focused on a handful of top recipients.

#837
of 1,925 companies
0.0%
of all US industry payments
0.6%
paid to its single top recipient
1
payment categories

How Boehringer Ingelheim Espana S.A. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Boehringer Ingelheim Espana S.A.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$382,771 Top 43% higher than 57% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Boehringer Ingelheim Espana S.A.

In Program Year 2024, Boehringer Ingelheim Espana S.A. reported $382,770.85 in payments to 2 physicians and teaching hospitals across 32 individual transactions, an average of $12.0K per transaction and $191.4K per recipient. That total places Boehringer Ingelheim Espana S.A. at rank #837 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 1-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $1.6K, accounting for 0.4% of the company's reported total and 2 transactions.

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Boehringer Ingelheim Espana S.A.'s 1-category general-payment breakdown at $1.6K, 0.4% of the reported total.

How Boehringer Ingelheim Espana S.A. divides its payments

How the reported total splits across payment categories

1. Compensation for Services…$1.6K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.6K 2

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,575.36 (100.0%) of $1,575.36 in this company's General Payments records across 2 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Boehringer Ingelheim Espana S.A.

The five named recipients with the highest reported General Payments from this company

Stephen Marder$969.45Christoph U Correll$605.91
  1. 1

    Stephen Marder

    $969.45 across 1 reported transactions

  2. 2

    Christoph U Correll

    $605.91 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $12.0K. Average per recipient: $191.4K.

Total Amount

$382,770.85

Avg per Transaction

$12.0K

Avg per Recipient

$191.4K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Boehringer Ingelheim Espana S.A. Share

0.0%

#837 by total payments

Frequently Asked Questions

How much did Boehringer Ingelheim Espana S.A. pay to physicians and hospitals in 2024?
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Boehringer Ingelheim Espana S.A., totaling $382,770.85 across 32 transactions to physicians and hospitals.
How many physicians received payments from Boehringer Ingelheim Espana S.A.?
Boehringer Ingelheim Espana S.A. made payments to 2 physicians and teaching hospitals in 2024. The average payment per recipient was $191.4K.
What types of payments did Boehringer Ingelheim Espana S.A. make?
Boehringer Ingelheim Espana S.A. made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $1.6K, representing 0.4% of the company's reported total.
How does Boehringer Ingelheim Espana S.A. rank among pharmaceutical companies?
By total payment amount, Boehringer Ingelheim Espana S.A. sits at #837 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Boehringer Ingelheim Espana S.A.?
In 2024, Boehringer Ingelheim Espana S.A. averaged $12.0K per transaction across 32 transactions to 2 recipients.
Where does the payment data for Boehringer Ingelheim Espana S.A. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Boehringer Ingelheim Espana S.A.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.